Witnesses testifying before the Senate Special Committee on Aging, and committee members themselves, called for more funding for Alzheimer’s research at an April 6 hearing.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
3 FDA advisory panel members resign in wake of controversial approval of new Alzheimer’s drug
By
Kimberly Bonvissuto
Jun 11, 2021
Three members of a Food & Drug Administration advisory panel resigned this week over the agency’s controversial decision on Monday to approve a novel therapy for Alzheimer’s disease.
Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.
Napping may be a sign of approaching Alzheimer’s
By
John O'Connor
Aug 13, 2019
When residents begin to take more naps, it might not just be that they are tired. New research indicates it might be an early warning sign of advancing Alzheimer’s disease.
Spa program reduces use of antipsychotics, other meds in memory care residents
By
Kimberly Bonvissuto
Mar 14, 2022
When Sunshine Retirement Living officials saw a significant drop in the use of antipsychotics in its memory care residents after piloting a “sensory spa” in one community, its mission became clear....
Kentucky bill would set training standards for home health agencies
By
Joe Jancsurak
Jan 19, 2021
Legislation proposed in Kentucky would set minimum training standards for home health agencies caring for people with Alzheimer’s disease.
Brain-stimulating activities can lower risk of mild cognitive impairment
By
Lois A. Bowers
Jan 30, 2017
Playing games, making crafts, using a computer and engaging in social activities can help older adults decrease the risk of developing mild cognitive impairment, according to research published Monday.
Expert panel publishes first recommendations on appropriate use of Alzhemier’s drug Aduhelm
By
Kimberly Bonvissuto
Jul 27, 2021
A panel of experts in the Alzheimer’s field this morning published the first recommendations for the appropriate use of aducanumab (Aduhelm), the controversial new drug to treat early, mild disease.
Stable body mass index tied to slower cognitive decline in older adults
Jan 25, 2022
The findings were seen regardless of whether a person has normal, overweight or obese body mass index at baseline.